The non‐human primate model of tuberculosis

Non‐human primates (NHPs) are used to model human disease owing to their remarkably similar genomes, physiology, and immune systems. Recently, there has been an increased interest in modeling tuberculosis (TB) in NHPs. Macaques are susceptible to infection with different strains of Mycobacterium tuberculosis (Mtb), producing the full spectrum of disease conditions, including latent infection, chronic progressive infection, and acute TB, depending on the route and dose of infection. Clearly, NHPs are an excellent model of human TB. While the initial aim of the NHP model was to allow preclinical testing of candidate vaccines and drugs, it is now also being used to study pathogenesis and immune correlates of protection. Recent advances in this field are discussed in this review. Key questions such as the effect of hypoxia on the biology of Mtb and the basis of reactivation of latent TB can now be investigated through the use of this model.

[1]  W. Barclay,et al.  Aerosol-Induced Tuberculosis in Subhuman Primates and the Course of the Disease After Intravenous BCG Vaccination , 1970, Infection and immunity.

[2]  R. Good,et al.  Tuberculin-induced lymphocyte transformation and skin reactivity in monkeys vaccinated or not vaccinated with Bacille Calmette-Guérin, then challenged with virulent Mycobacterium tuberculosis. , 1975, The American review of respiratory disease.

[3]  R. Koch.  The Etiology of Tuberculosis , 1982 .

[4]  R. Koch.  Classics in infectious diseases. The etiology of tuberculosis: Robert Koch. Berlin, Germany 1882. , 1982, Reviews of infectious diseases.

[5]  P. Yeni,et al.  Mycobacterium tuberculosis infections , 1993 .

[6]  M. Horwitz,et al.  The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease , 1996, Nature Medicine.

[7]  C. Dye,et al.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.

[8]  D. Waag,et al.  Evaluation of cynomolgus (Macaca fascicularis) and rhesus (Macaca mulatta) monkeys as experimental models of acute Q fever after aerosol exposure to phase-I Coxiella burnetii. , 1999, Laboratory animal science.

[9]  B. Murphy,et al.  African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1, -2, and -3 infection. , 2000, Vaccine.

[10]  J. Lifson,et al.  Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention. , 2000, Advances in pharmacology.

[11]  J. Flynn,et al.  Effect of mycobacterial infection on virus loads and disease progression in simian immunodeficiency virus-infected rhesus monkeys. , 2000, AIDS research and human retroviruses.

[12]  S. Emerson,et al.  Animal models of hepatitis A and E. , 2001, ILAR journal.

[13]  R. Coler,et al.  Protection against Cutaneous Leishmaniasis Induced by Recombinant Antigens in Murine and Nonhuman Primate Models of the Human Disease , 2001, Infection and Immunity.

[14]  M. Simon,et al.  Antiretroviral Agents Restore Mycobacterium-Specific T-Cell Immune Responses and Facilitate Controlling a Fatal Tuberculosis-Like Disease in Macaques Coinfected with Simian Immunodeficiency Virus andMycobacterium bovis BCG , 2001, Journal of Virology.

[15]  E. Rubin,et al.  Comprehensive identification of conditionally essential genes in mycobacteria , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Thomas,et al.  Divergent effect of bacillus Calmette–Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: Implications for primate models in tuberculosis vaccine research , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Simon,et al.  Adaptive Immune Response of Vγ2Vδ2+ T Cells During Mycobacterial Infections , 2002, Science.

[18]  M. Simon,et al.  Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. , 2002, Science.

[19]  L. Ramakrishnan,et al.  Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. , 2002, Immunity.

[20]  M. Simon,et al.  Induction of an AIDS Virus-Related Tuberculosis-Like Disease in Macaques: a Model of Simian Immunodeficiency Virus- Mycobacterium Coinfection , 2002, Infection and Immunity.

[21]  B. Gormus,et al.  Spectrum of manifestations of Mycobacterium tuberculosis infection in primates infected with SIV. , 2003, AIDS research and human retroviruses.

[22]  JoAnne L. Flynn,et al.  Experimental Mycobacterium tuberculosis Infection of Cynomolgus Macaques Closely Resembles the Various Manifestations of Human M. tuberculosis Infection , 2003, Infection and Immunity.

[23]  Martin Tompa,et al.  Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis , 2003, Molecular microbiology.

[24]  J. Musser,et al.  Group A Streptococcus Gene Expression in Humans and Cynomolgus Macaques with Acute Pharyngitis , 2003, Infection and Immunity.

[25]  B. Gormus,et al.  Evidence for a rhesus monkey model of asymptomatic tuberculosis , 2004, Journal of medical primatology.

[26]  D. Sherman,et al.  Two Sensor Kinases Contribute to the Hypoxic Response of Mycobacterium tuberculosis* , 2004, Journal of Biological Chemistry.

[27]  N. Letvin,et al.  Development of Vγ2Vδ2+ T Cell Responses during Active Mycobacterial Coinfection of Simian Immunodeficiency Virus-Infected Macaques Requires Control of Viral Infection and Immune Competence of CD4+ T Cells , 2004 .

[28]  S. Kaufmann,et al.  Mycobacterium tuberculosis and the host response , 2005, The Journal of experimental medicine.

[29]  E. Rubin,et al.  Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Thomas,et al.  Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. , 2005, Vaccine.

[31]  G. Beamer,et al.  Murine models of susceptibility to tuberculosis. , 2005, Archivum immunologiae et therapiae experimentalis.

[32]  S. Primack,et al.  High resolution radiographic and fine immunologic definition of TB disease progression in the rhesus macaque. , 2006, Microbes and infection.

[33]  T. Slezak,et al.  Cynomolgus Macaque as an Animal Model for Severe Acute Respiratory Syndrome , 2006, PLoS medicine.

[34]  A. Myers,et al.  Early Events in Mycobacterium tuberculosis Infection in Cynomolgus Macaques , 2006, Infection and Immunity.

[35]  J. Flynn,et al.  Lessons from experimental Mycobacterium tuberculosis infections. , 2006, Microbes and infection.

[36]  David G. Russell,et al.  Who puts the tubercle in tuberculosis? , 2007, Nature Reviews Microbiology.

[37]  Helen A Fletcher,et al.  Correlates of immune protection from tuberculosis. , 2007, Current molecular medicine.

[38]  A. Lackner,et al.  Current concepts in AIDS pathogenesis: insights from the SIV/macaque model. , 2007, Annual review of medicine.

[39]  H. McClure,et al.  Dose-Response Model for Listeria monocytogenes-Induced Stillbirths in Nonhuman Primates , 2007, Infection and Immunity.

[40]  V. A. Stewart,et al.  Preclinical Evaluation of the Safety and Immunogenicity of a Vaccine Consisting of Plasmodium falciparum Liver-Stage Antigen 1 with Adjuvant AS01B Administered Alone or Concurrently with the RTS,S/AS01B Vaccine in Rhesus Primates , 2007, Infection and Immunity.

[41]  G. Bai,et al.  Worldwide Emergence of Extensively Drug-resistant Tuberculosis , 2007, Emerging infectious diseases.

[42]  W. Bishai,et al.  Extrapulmonary Dissemination of Mycobacterium bovis but Not Mycobacterium tuberculosis in a Bronchoscopic Rabbit Model of Cavitary Tuberculosis , 2008, Infection and Immunity.

[43]  B. Haynes,et al.  Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. , 2008, The Journal of infectious diseases.

[44]  D. Swenson,et al.  Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses , 2008, Expert review of vaccines.

[45]  James A. Raleigh,et al.  Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates , 2008, Infection and Immunity.

[46]  A. Hickey,et al.  The guinea pig as a model of infectious diseases. , 2008, Comparative medicine.

[47]  A. Thomas,et al.  MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques , 2009, PloS one.

[48]  R. Coler,et al.  Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys , 2009, Proceedings of the National Academy of Sciences.

[49]  B. Haynes,et al.  Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates. , 2009, Vaccine.

[50]  D. Crane,et al.  Chlamydia trachomatis Native Major Outer Membrane Protein Induces Partial Protection in Nonhuman Primates: Implication for a Trachoma Transmission-Blocking Vaccine1 , 2009, The Journal of Immunology.

[51]  JoAnne L. Flynn,et al.  Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model , 2009, Infection and Immunity.

[52]  F. Gleeson,et al.  Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis. , 2009, Tuberculosis.

[53]  William R. Jacobs,et al.  A Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis , 2009, PLoS pathogens.

[54]  T. Taniyama,et al.  Protective efficacy of recombinant BCG Tokyo (Ag85A) in rhesus monkeys (Macaca mulatta) infected intratracheally with H37Rv Mycobacterium tuberculosis. , 2009, Tuberculosis.

[55]  M. Harrington.  From HIV to tuberculosis and back again: a tale of activism in 2 pandemics. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  G. Zeng,et al.  Differentiation, distribution and {gamma}{delta} T cell-driven regulation of IL-22-producing T cells in tuberculosis , 2010 .

[57]  M. Quail,et al.  Tuberculous Granuloma Induction via Interaction of a Bacterial Secreted Protein with Host Epithelium , 2010, Science.

[58]  D. Kaushal,et al.  Transcriptional Reprogramming in Nonhuman Primate (Rhesus Macaque) Tuberculosis Granulomas , 2010, PloS one.

[59]  J. Flynn,et al.  CD4(+) regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infection. , 2010, The Journal of infectious diseases.

[60]  S. Staprans,et al.  Role of nonhuman primates in the evaluation of candidate AIDS vaccines: an industry perspective , 2010, Current opinion in HIV and AIDS.

[61]  Nicholas A. Be,et al.  Genetic requirements for the survival of tubercle bacilli in primates. , 2010, The Journal of infectious diseases.

[62]  John P. Moore,et al.  Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor. , 2010, The Journal of infectious diseases.

[63]  N. Twenhafel.  Pathology of Inhalational Anthrax Animal Models , 2010, Veterinary pathology.

[64]  R. Kennedy,et al.  Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine. , 2010, The Journal of infectious diseases.

[65]  C. Schmaljohn,et al.  Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates. , 2010, Vaccine.

[66]  Sangita B. Patil,et al.  Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS. , 2010, The Journal of infectious diseases.

[67]  A. Myers,et al.  Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. , 2010, Arthritis and rheumatism.

[68]  C. Broder,et al.  Development of an Acute and Highly Pathogenic Nonhuman Primate Model of Nipah Virus Infection , 2010, PloS one.

[69]  Timothy J. Sturgeon,et al.  Reactivation of Latent Tuberculosis in Cynomolgus Macaques Infected with SIV Is Associated with Early Peripheral T Cell Depletion and Not Virus Load , 2010, PloS one.

[70]  G. Zeng,et al.  Differentiation, Distribution and γδ T Cell-Driven Regulation of IL-22-Producing T Cells in Tuberculosis , 2010, PLoS pathogens.

[71]  Adrian V. S. Hill,et al.  Establishment of an Aerosol Challenge Model of Tuberculosis in Rhesus Macaques and an Evaluation of Endpoints for Vaccine Testing , 2010, Clinical and Vaccine Immunology.

[72]  J. Flynn,et al.  Simian Immunodeficiency Virus-Induced Changes in T Cell Cytokine Responses in Cynomolgus Macaques with Latent Mycobacterium tuberculosis Infection Are Associated with Timing of Reactivation , 2011, The Journal of Immunology.

[73]  V. Mizrahi,et al.  Functional Analysis of Molybdopterin Biosynthesis in Mycobacteria Identifies a Fused Molybdopterin Synthase in Mycobacterium tuberculosis , 2010, Journal of bacteriology.

[74]  J. Flynn,et al.  CD 4 Regulatory T cells in a Cynomolgus Macaque Model of Mycobacterium tuberculosis Infection 1 , 2 , 3 , 2011 .

[75]  P. Jahrling,et al.  Cowpox virus infection of cynomolgus macaques as a model of hemorrhagic smallpox. , 2011, Virology.

[76]  J. Blanchard,et al.  Reactivation of latent tuberculosis in rhesus macaques by coinfection with simian immunodeficiency virus , 2011, Journal of medical primatology.

[77]  K. Mansfield,et al.  Extended safety and efficacy studies of a live attenuated double leucine and pantothenate auxotroph of Mycobacterium tuberculosis as a vaccine candidate. , 2011, Vaccine.

[78]  G. Zeng,et al.  Membrane-Bound IL-22 after De Novo Production in Tuberculosis and Anti-Mycobacterium tuberculosis Effector Function of IL-22+ CD4+ T Cells , 2011, The Journal of Immunology.

[79]  Rachel Brower-Sinning,et al.  Large Scale Comparison of Innate Responses to Viral and Bacterial Pathogens in Mouse and Macaque , 2011, PloS one.

[80]  M. Lackemeyer,et al.  Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. , 2011, Microbes and infection.

[81]  R. Schinazi,et al.  Simian immunodeficiency virus macaque models of HIV latency , 2011, Current opinion in HIV and AIDS.

[82]  M. Chase,et al.  Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection , 2011, Nature Genetics.

[83]  Thomas R. Ioerger,et al.  High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol Catabolism , 2011, PLoS pathogens.

[84]  P. Luciw,et al.  Stereological analysis of bacterial load and lung lesions in nonhuman primates (rhesus macaques) experimentally infected with Mycobacterium tuberculosis. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[85]  C. F. von Reyn,et al.  Disseminated tuberculosis in human immunodeficiency virus infection: ineffective immunity, polyclonal disease and high mortality. , 2011, The International Journal of Tuberculosis and Lung Disease.

[86]  U. Varshney,et al.  Distinct mechanisms of DNA repair in mycobacteria and their implications in attenuation of the pathogen growth , 2012, Mechanisms of Ageing and Development.

[87]  M. Kuroda,et al.  The Mycobacterium tuberculosis stress response factor SigH is required for bacterial burden as well as immunopathology in primate lungs. , 2012, The Journal of infectious diseases.

[88]  D. Sherman,et al.  The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. , 2012, The Journal of clinical investigation.